Alexandre M. Sorlin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexandre M. Sorlin has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- David Meybin Wilson
Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA
3 shared publications - Hien M. Nguyen
Wayne State University
3 shared publications - Jason C. Mixdorf
Department of Chemistry , University of Iowa , Iowa City , Iowa 52242 , United States
3 shared publications Joanne Engel
Department of Medicine, University of California, San Francisco, San Francisco, California 94158, United States
3 shared publicationsJoseph Blecha
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States
3 shared publications- Marina López-Álvarez
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States
3 shared publications
Latest Publications
- Open Access
- 4 December 2025
- Published by Wiley in Angewandte Chemie
18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
The development of 18 F‐labelled radiotracers is of vital importance for (pre)clinical positron emission tomography (PET) imaging and to guide drug discovery campaigns. State‐of‐the‐art approaches often require labour‐intensive preparation of highly functionalised radiolabelling precursors. This bottleneck impedes analogue generation for optimal imaging and exploration of radiochemical space. To this end, we disclose a nickel‐mediated aryl (C) sp 2 ‐(C) sp 3 cross‐coupling with amine‐derived alkyl 2,4,6‐triphenylpyridinium salts as coupling partners amenable to radiosynthesis. The method was applied to primary and secondary 2,4,6‐triphenylpyridinium salts in radiochemical conversion (RCC) up to 86% and a high‐throughput experimentation (HTE) assay proved crucial for expedient ligand evaluation. A late‐stage diversification case study from a sole precursor achieved six 18 F‐labelled GSK‐3 kinase inhibitor analogues, one being prepared in up to gigabecquerel (GBq) quantities in a (semi)automated two‐step protocol applied across three commercial radiosynthesis platforms.
- 4 December 2025
- Published by Wiley in Angewandte Chemie
Open Access18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
The development of 18 F‐labelled radiotracers is of vital importance for (pre)clinical positron emission tomography (PET) imaging and to guide drug discovery campaigns. State‐of‐the‐art approaches often require labour‐intensive preparation of highly functionalised radiolabelling precursors. This bottleneck impedes analogue generation for optimal imaging and exploration of radiochemical space. To this end, we disclose a nickel‐mediated aryl (C) sp 2 ‐(C) sp 3 cross‐coupling with amine‐derived alkyl 2,4,6‐triphenylpyridinium salts as coupling partners amenable to radiosynthesis. The method was applied to primary and secondary 2,4,6‐triphenylpyridinium salts in radiochemical conversion (RCC) up to 86% and a high‐throughput experimentation (HTE) assay proved crucial for expedient ligand evaluation. A late‐stage diversification case study from a sole precursor achieved six 18 F‐labelled GSK‐3 kinase inhibitor analogues, one being prepared in up to gigabecquerel (GBq) quantities in a (semi)automated two‐step protocol applied across three commercial radiosynthesis platforms.
- Open Access
- 4 December 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (4) , e22650
18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
The development of 18 F‐labelled radiotracers is of vital importance for (pre)clinical positron emission tomography (PET) imaging and to guide drug discovery campaigns. State‐of‐the‐art approaches often require labour‐intensive preparation of highly functionalised radiolabelling precursors. This bottleneck impedes analogue generation for optimal imaging and exploration of radiochemical space. To this end, we disclose a nickel‐mediated aryl (C) sp 2 ‐(C) sp 3 cross‐coupling with amine‐derived alkyl 2,4,6‐triphenylpyridinium salts as coupling partners amenable to radiosynthesis. The method was applied to primary and secondary 2,4,6‐triphenylpyridinium salts in radiochemical conversion (RCC) up to 86% and a high‐throughput experimentation (HTE) assay proved crucial for expedient ligand evaluation. A late‐stage diversification case study from a sole precursor achieved six 18 F‐labelled GSK‐3 kinase inhibitor analogues, one being prepared in up to gigabecquerel (GBq) quantities in a (semi)automated two‐step protocol applied across three commercial radiosynthesis platforms.
- 4 December 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (4) , e22650
Open Access18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
The development of 18 F‐labelled radiotracers is of vital importance for (pre)clinical positron emission tomography (PET) imaging and to guide drug discovery campaigns. State‐of‐the‐art approaches often require labour‐intensive preparation of highly functionalised radiolabelling precursors. This bottleneck impedes analogue generation for optimal imaging and exploration of radiochemical space. To this end, we disclose a nickel‐mediated aryl (C) sp 2 ‐(C) sp 3 cross‐coupling with amine‐derived alkyl 2,4,6‐triphenylpyridinium salts as coupling partners amenable to radiosynthesis. The method was applied to primary and secondary 2,4,6‐triphenylpyridinium salts in radiochemical conversion (RCC) up to 86% and a high‐throughput experimentation (HTE) assay proved crucial for expedient ligand evaluation. A late‐stage diversification case study from a sole precursor achieved six 18 F‐labelled GSK‐3 kinase inhibitor analogues, one being prepared in up to gigabecquerel (GBq) quantities in a (semi)automated two‐step protocol applied across three commercial radiosynthesis platforms.
- Open Access
- 14 March 2024
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (4) , 517-527
Bioorthogonal Radiolabeling of Azide-Modified Bacteria Using [18F]FB-sulfo-DBCO
Purpose: This study was motivated by the need for better positron emission tomography (PET)-compatible tools to image bacterial infection. Our previous efforts have targeted bacteria-specific metabolism via assimilation of carbon-11 labeled d-amino acids into the bacterial cell wall. Since the chemical determinants of this incorporation are not fully understood, we sought a high-throughput method to label d-amino acid derived structures with fluorine-18. Our strategy employed a chemical biology approach, whereby an azide (-N3) bearing d-amino acid is incorporated into peptidoglycan muropeptides, with subsequent "click" cycloaddition with an 18F-labeled strained cyclooctyne partner. Procedures: A water-soluble, 18F-labeled and dibenzocyclooctyne (DBCO)-derived radiotracer ([18F]FB-sulfo-DBCO) was synthesized. This tracer was incubated with pathogenic bacteria treated with azide-bearing d-amino acids, and incorporated 18F was determined via gamma counting. In vitro uptake in bacteria previously treated with azide-modified d-amino acids was compared to that in cultures treated with amino acid controls. The biodistribution of [18F]FB-sulfo-DBCO was studied in a cohort of healthy mice with implications for future in vivo imaging. Results: The new strain-promoted azide-alkyne cycloaddition (SPAAC) radiotracer [18F]FB-sulfo-DBCO was synthesized with high radiochemical yield and purity via N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB). Accumulation of [18F]FB-sulfo-DBCO was significantly higher in several bacteria treated with azide-modified d-amino acids than in controls; for example, we observed 7 times greater [18F]FB-sulfo-DBCO ligation in Staphylococcus aureus cultures incubated with 3-azido-d-alanine versus those incubated with d-alanine. Conclusions: The SPAAC radiotracer [18F]FB-sulfo-DBCO was validated in vitro via metabolic labeling of azide-bearing peptidoglycan muropeptides. d-Amino acid-derived PET radiotracers may be more efficiently screened via [18F]FB-sulfo-DBCO modification.
- 14 March 2024
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (4) , 517-527
Open AccessBioorthogonal Radiolabeling of Azide-Modified Bacteria Using [18F]FB-sulfo-DBCO
Purpose: This study was motivated by the need for better positron emission tomography (PET)-compatible tools to image bacterial infection. Our previous efforts have targeted bacteria-specific metabolism via assimilation of carbon-11 labeled d-amino acids into the bacterial cell wall. Since the chemical determinants of this incorporation are not fully understood, we sought a high-throughput method to label d-amino acid derived structures with fluorine-18. Our strategy employed a chemical biology approach, whereby an azide (-N3) bearing d-amino acid is incorporated into peptidoglycan muropeptides, with subsequent "click" cycloaddition with an 18F-labeled strained cyclooctyne partner. Procedures: A water-soluble, 18F-labeled and dibenzocyclooctyne (DBCO)-derived radiotracer ([18F]FB-sulfo-DBCO) was synthesized. This tracer was incubated with pathogenic bacteria treated with azide-bearing d-amino acids, and incorporated 18F was determined via gamma counting. In vitro uptake in bacteria previously treated with azide-modified d-amino acids was compared to that in cultures treated with amino acid controls. The biodistribution of [18F]FB-sulfo-DBCO was studied in a cohort of healthy mice with implications for future in vivo imaging. Results: The new strain-promoted azide-alkyne cycloaddition (SPAAC) radiotracer [18F]FB-sulfo-DBCO was synthesized with high radiochemical yield and purity via N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB). Accumulation of [18F]FB-sulfo-DBCO was significantly higher in several bacteria treated with azide-modified d-amino acids than in controls; for example, we observed 7 times greater [18F]FB-sulfo-DBCO ligation in Staphylococcus aureus cultures incubated with 3-azido-d-alanine versus those incubated with d-alanine. Conclusions: The SPAAC radiotracer [18F]FB-sulfo-DBCO was validated in vitro via metabolic labeling of azide-bearing peptidoglycan muropeptides. d-Amino acid-derived PET radiotracers may be more efficiently screened via [18F]FB-sulfo-DBCO modification.
- Open Access
- 25 February 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (3) , 1039-1047
Peptidoglycan-Targeted [18F]3,3,3-Trifluoro-d-alanine Tracer for Imaging Bacterial Infection
Imaging is increasingly used to detect and monitor bacterial infection. Both anatomic (X-rays, computed tomography, ultrasound, and MRI) and nuclear medicine ([111In]-WBC SPECT, [18F]FDG PET) techniques are used in clinical practice but lack specificity for the causative microorganisms themselves. To meet this challenge, many groups have developed imaging methods that target pathogen-specific metabolism, including PET tracers integrated into the bacterial cell wall. We have previously reported the d-amino acid derived PET radiotracers d-methyl-[11C]-methionine, d-[3-11C]-alanine, and d-[3-11C]-alanine-d-alanine, which showed robust bacterial accumulation in vitro and in vivo. Given the clinical importance of radionuclide half-life, in the current study, we developed [18F]3,3,3-trifluoro-d-alanine (d-[18F]-CF3-ala), a fluorine-18 labeled tracer. We tested the hypothesis that d-[18F]-CF3-ala would be incorporated into bacterial peptidoglycan given its structural similarity to d-alanine itself. NMR analysis showed that the fluorine-19 parent amino acid d-[19F]-CF3-ala was stable in human and mouse serum. d-[19F]-CF3-ala was also a poor substrate for d-amino acid oxidase, the enzyme largely responsible for mammalian d-amino acid metabolism and a likely contributor to background signals using d-amino acid derived PET tracers. In addition, d-[19F]-CF3-ala showed robust incorporation into Escherichia coli peptidoglycan, as detected by HPLC/mass spectrometry. Based on these promising results, we developed a radiosynthesis of d-[18F]-CF3-ala via displacement of a bromo-precursor with [18F]fluoride followed by chiral stationary phase HPLC. Unexpectedly, the accumulation of d-[18F]-CF3-ala by bacteria in vitro was highest for Gram-negative pathogens in particular E. coli. In a murine model of acute bacterial infection, d-[18F]-CF3-ala could distinguish live from heat-killed E. coli, with low background signals. These results indicate the viability of [18F]-modified d-amino acids for infection imaging and indicate that improved specificity for bacterial metabolism can improve tracer performance.
- 25 February 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (3) , 1039-1047
Open AccessPeptidoglycan-Targeted [18F]3,3,3-Trifluoro-d-alanine Tracer for Imaging Bacterial Infection
Imaging is increasingly used to detect and monitor bacterial infection. Both anatomic (X-rays, computed tomography, ultrasound, and MRI) and nuclear medicine ([111In]-WBC SPECT, [18F]FDG PET) techniques are used in clinical practice but lack specificity for the causative microorganisms themselves. To meet this challenge, many groups have developed imaging methods that target pathogen-specific metabolism, including PET tracers integrated into the bacterial cell wall. We have previously reported the d-amino acid derived PET radiotracers d-methyl-[11C]-methionine, d-[3-11C]-alanine, and d-[3-11C]-alanine-d-alanine, which showed robust bacterial accumulation in vitro and in vivo. Given the clinical importance of radionuclide half-life, in the current study, we developed [18F]3,3,3-trifluoro-d-alanine (d-[18F]-CF3-ala), a fluorine-18 labeled tracer. We tested the hypothesis that d-[18F]-CF3-ala would be incorporated into bacterial peptidoglycan given its structural similarity to d-alanine itself. NMR analysis showed that the fluorine-19 parent amino acid d-[19F]-CF3-ala was stable in human and mouse serum. d-[19F]-CF3-ala was also a poor substrate for d-amino acid oxidase, the enzyme largely responsible for mammalian d-amino acid metabolism and a likely contributor to background signals using d-amino acid derived PET tracers. In addition, d-[19F]-CF3-ala showed robust incorporation into Escherichia coli peptidoglycan, as detected by HPLC/mass spectrometry. Based on these promising results, we developed a radiosynthesis of d-[18F]-CF3-ala via displacement of a bromo-precursor with [18F]fluoride followed by chiral stationary phase HPLC. Unexpectedly, the accumulation of d-[18F]-CF3-ala by bacteria in vitro was highest for Gram-negative pathogens in particular E. coli. In a murine model of acute bacterial infection, d-[18F]-CF3-ala could distinguish live from heat-killed E. coli, with low background signals. These results indicate the viability of [18F]-modified d-amino acids for infection imaging and indicate that improved specificity for bacterial metabolism can improve tracer performance.
- Open Access
- 22 November 2023
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 8 (12) , 4554-4565
Imaging the Bacterial Cell Wall Using N-Acetyl Muramic Acid-Derived Positron Emission Tomography Radiotracers
Imaging infections in patients is challenging using conventional methods, motivating the development of positron emission tomography (PET) radiotracers targeting bacteria-specific metabolic pathways. Numerous techniques have focused on the bacterial cell wall, although peptidoglycan-targeted PET tracers have been generally limited to the short-lived carbon-11 radioisotope (t(1/2) = 20.4 min). In this article, we developed and tested new tools for infection imaging using an amino sugar component of peptidoglycan, namely, derivatives of N-acetyl muramic acid (NAM) labeled with the longer-lived fluorine-18 (t(1/2) = 109.6 min) radioisotope. Muramic acid was reacted directly with 4-nitrophenyl 2-[F-18]fluoropropionate ([F-18]NFP) to afford the enantiomeric NAM derivatives (S)-[F-18]FMA and (R)-[F-18]FMA. Both diastereomers were easily isolated and showed robust accumulation by human pathogens in vitro and in vivo, including Staphylococcus aureus. These results form the basis for future clinical studies using fluorine-18-labeled NAM-derived PET radiotracers.
- 22 November 2023
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 8 (12) , 4554-4565
Open AccessImaging the Bacterial Cell Wall Using N-Acetyl Muramic Acid-Derived Positron Emission Tomography Radiotracers
Imaging infections in patients is challenging using conventional methods, motivating the development of positron emission tomography (PET) radiotracers targeting bacteria-specific metabolic pathways. Numerous techniques have focused on the bacterial cell wall, although peptidoglycan-targeted PET tracers have been generally limited to the short-lived carbon-11 radioisotope (t(1/2) = 20.4 min). In this article, we developed and tested new tools for infection imaging using an amino sugar component of peptidoglycan, namely, derivatives of N-acetyl muramic acid (NAM) labeled with the longer-lived fluorine-18 (t(1/2) = 109.6 min) radioisotope. Muramic acid was reacted directly with 4-nitrophenyl 2-[F-18]fluoropropionate ([F-18]NFP) to afford the enantiomeric NAM derivatives (S)-[F-18]FMA and (R)-[F-18]FMA. Both diastereomers were easily isolated and showed robust accumulation by human pathogens in vitro and in vivo, including Staphylococcus aureus. These results form the basis for future clinical studies using fluorine-18-labeled NAM-derived PET radiotracers.
- 22 August 2019
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (37) , 14843-14852
The Role of Trichloroacetimidate To Enable Iridium-Catalyzed Regio- and Enantioselective Allylic Fluorination: A Combined Experimental and Computational Study
Asymmetric allylic fluorination has proven to be a robust and efficient methodology with potential applications for the development of pharmaceuticals and practical synthesis for 18F-radiolabeling. Although there have been several efficient methods reported for the regioselective formation of allylic fluorides, there are few approaches available for the asymmetric synthesis of allyl fluorides. In 2011, initial studies toward a regioselective allylic fluorination reaction were undertaken in our laboratory. In our approach, allylic trichloroacetimidates were employed as electrophiles, Et3N•3HF as a nucleophilic fluoride source, and cyclooctadiene iridium chloride dimer, [Ir(COD)Cl]2, as a catalyst leading to the formation of branched allylic fluorides in good yields and excellent regioselectivities. In subsequent studies, racemic secondary allylic trichloroacetimidates were transformed to enantioenriched allylic fluorides catalyzed by a chiral bicyclo[3.3.0]octadiene (S,S)-ligated iridium complex. Herein, we report a detailed investigation that provides insight into the mechanism and origin of regio- and enantioselectivity of the iridium-catalyzed allylic fluorination. A synergistic computational and experimental study provides strong support for a dynamic kinetic asymmetric transformation (DYKAT) of racemic allylic trichloroacetimidate, leading to regio- and enantioselective allylic C-F bond formation. This combined study also highlights the dualistic nature of the trichloroacetimidate as a leaving/directing group and as a ligand to facilitate equilibration of diastereomeric π-allyl iridium intermediates via a pi-sigma-pi mechanism, leading to enantioenriched allylic fluorides.
- 22 August 2019
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (37) , 14843-14852
The Role of Trichloroacetimidate To Enable Iridium-Catalyzed Regio- and Enantioselective Allylic Fluorination: A Combined Experimental and Computational Study
Asymmetric allylic fluorination has proven to be a robust and efficient methodology with potential applications for the development of pharmaceuticals and practical synthesis for 18F-radiolabeling. Although there have been several efficient methods reported for the regioselective formation of allylic fluorides, there are few approaches available for the asymmetric synthesis of allyl fluorides. In 2011, initial studies toward a regioselective allylic fluorination reaction were undertaken in our laboratory. In our approach, allylic trichloroacetimidates were employed as electrophiles, Et3N•3HF as a nucleophilic fluoride source, and cyclooctadiene iridium chloride dimer, [Ir(COD)Cl]2, as a catalyst leading to the formation of branched allylic fluorides in good yields and excellent regioselectivities. In subsequent studies, racemic secondary allylic trichloroacetimidates were transformed to enantioenriched allylic fluorides catalyzed by a chiral bicyclo[3.3.0]octadiene (S,S)-ligated iridium complex. Herein, we report a detailed investigation that provides insight into the mechanism and origin of regio- and enantioselectivity of the iridium-catalyzed allylic fluorination. A synergistic computational and experimental study provides strong support for a dynamic kinetic asymmetric transformation (DYKAT) of racemic allylic trichloroacetimidate, leading to regio- and enantioselective allylic C-F bond formation. This combined study also highlights the dualistic nature of the trichloroacetimidate as a leaving/directing group and as a ligand to facilitate equilibration of diastereomeric π-allyl iridium intermediates via a pi-sigma-pi mechanism, leading to enantioenriched allylic fluorides.
- 21 December 2018
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 21 (1) , 60-64
Iridium-Catalyzed Radiosynthesis of Branched Allylic [18F]Fluorides
The rapid and operationally simple radiosynthesis of branched allylic [18F]fluorides bearing a variety of functional groups, via iridium-catalyzed nucleophilic substitution reaction utilizing allylic trichloroacetimidates and [18F]KF·Kryptofix[2.2.2] complex in 5–15 min at room temperature, is reported. The versatility of the allyl functional group of the resulting radiofluorinated products offers the benefit of being subsequently available for further functionalization.
- 21 December 2018
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 21 (1) , 60-64
Iridium-Catalyzed Radiosynthesis of Branched Allylic [18F]Fluorides
The rapid and operationally simple radiosynthesis of branched allylic [18F]fluorides bearing a variety of functional groups, via iridium-catalyzed nucleophilic substitution reaction utilizing allylic trichloroacetimidates and [18F]KF·Kryptofix[2.2.2] complex in 5–15 min at room temperature, is reported. The versatility of the allyl functional group of the resulting radiofluorinated products offers the benefit of being subsequently available for further functionalization.
- 29 December 2017
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 8 (2) , 790-801
Asymmetric Synthesis of Allylic Fluorides via Fluorination of Racemic Allylic Trichloroacetimidates Catalyzed by a Chiral Diene-Iridium Complex
- 29 December 2017
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 8 (2) , 790-801
Asymmetric Synthesis of Allylic Fluorides via Fluorination of Racemic Allylic Trichloroacetimidates Catalyzed by a Chiral Diene-Iridium Complex